The ion channel transient receptor potential melastatin-2 does not play a role in inflammatory mouse models of chronic obstructive pulmonary diseases by Hardaker, Liz et al.
RESEARCH Open Access
The ion channel transient receptor potential
melastatin-2 does not play a role in inflammatory
mouse models of chronic obstructive pulmonary
diseases
Liz Hardaker
1, Parmjit Bahra
1, Benjamin Cochin de Billy
2, Mark Freeman
1, Natalia Kupfer
1, Daniel Wyss
2 and
Alexandre Trifilieff
2*
Abstract
Background: There is strong evidence that oxidative stress is associated with the pathogenesis of chronic
obstructive pulmonary disease (COPD). The transient receptor potential melastatin-2 (TRPM2) is an oxidative stress
sensing channel that is expressed in a number of inflammatory cells and therefore it has been suggested that
inhibition of TRPM2 could lead to a beneficial effect in COPD patients. In this study, we have investigated the role
of TRPM2 in a variety of mouse models of oxidative stress and COPD using TRPM2-deficent mice.
Methods: Mice were exposed to ozone (3 ppm for 4 h) or lipopolysaccharide (LPS, 0.3 mg/kg, intranasaly). In another
model, mice were exposed to tobacco smoke (750 μg/l total wet particulate matter) for 30 min twice a day on three
consecutive days. For the exacerbation model, the smoke exposure on the morning of day 3 animals was replaced with
intranasal administration of LPS (0.3 mg/kg). Animals were killed 3 and 24 h after the challenge (ozone and LPS model)
or 18 h after the last tobacco smoke exposure. In vitro neutrophil chemotaxis and monocyte activation were also
studied using cells isolated from wild type and TRPM2-deficient animals. Statistical significance for the in vivo data (P <
0.05) was determined using analysis of variance with Kruskal-Wallis and Dunns multiple comparison test.
Results: In all models studied, no difference in the bronchoalveolar lavage inflammation could be evidenced when
comparing wild type and TRPM2-deficient mice. In addition, no difference could be seen in the lung inflammation
as assessed by the measurement of various cytokines/chemokines. Similarly in various in vitro cellular activation
assays using isolated neutrophils and monocytes no significant differences could be observed when comparing
wild type and TRPM2-deficient mice.
Discussion: We have shown, in all the models tested, no difference in the development of airway inflammation or
cell activation between TRPM2-deficient mice and their wild type counterparts. These results would suggest that
inhibiting TRPM2 activity in COPD would have no anti-inflammatory effect.
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Background
Chronic obstructive pulmonary disease (COPD) is a multi-
factorial disease involving inflammation, mucus produc-
tion dysregulation, lung parenchymal destruction and
systemic effects, all of which contribute to airflow
limitation. In developed countries, cigarette smoking is the
main aetiological agent of COPD and is believed to
account for approximately 90% of the cases [1]. The bur-
den of COPD on the healthcare system is enormous and it
is predicted that COPD will become the third leading
cause of death and the fourth commonest cause of disabil-
ity in the world by 2020 [2]. Despite that, pharmacothera-
pies available to these patients are mainly symptomatic
and none of them have been shown to alter the course of
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stress from cigarette smoking is associated with the patho-
genesis of COPD. In addition to this exogenous source of
oxidative stress, the chronic inflammation that takes place
in the lungs of COPD patients also contributes to the oxi-
dative stress and the pathogenesis of COPD [4]. This
would suggest that targeting the oxidative stress burden in
COPD patients could lead to beneficial effect.
The vertebrate transient receptor potential ion channel
family is divided into six subfamilies; ankyrin (TRPAs),
canonical (TRPCs), melastatin (TRPM), mucolipin
(TRPMLs), polycystickidneydisease (TRPPs) and vanilloid
(TRPVs). This classification is based on protein sequence
homology and all family members have six putative trans-
membrane domains and a pore region between the fifth
and the sixth transmembrane domains. These proteins
assemble into homo- or hetero-tetramers to form active
cation channels [5]. A number of TRP subfamilies serve as
a sensor for a variety of chemical (menthol or acrolein)
and physical stimuli such as oxidative stress, temperature,
membrane potential changes and osmotic stress. Three of
the subfamilies have members reported to play a role in
the oxidative stress sensing. They are TRPA, TRPM and
TRPV [6]. Among the oxidative stress sensors, TRPM2 is
of interest since it has been shown to be expressed in a
number of inflammatory cells (i.e., neutrophil, macro-
phage, monocyte). In addition, TRPM2 has also been
shown to be activated by pro-inflammatory stimuli such as
lipopolysaccharide (LPS, a major component of the outer
cell wall of Gram-negative bacteria) and TNF-a. Since all
the above inflammatory cells and stimuli are thought to be
of importance in COPD pathogenesis, it has been sug-
gested that inhibition of TRPM2 could lead to a beneficial
effect in COPD patients [5].
In this study, we have investigated the role of TRPM2 in
a variety of mouse models of COPD and in vitro cell-
based assays using TRPM2-deficient mice [7]. Our results
show, in all the models tested, no difference in the devel-
opment of airway inflammation or cell activation between
TRPM2-deficient mice and their wild type counterpart.
These results would suggest that inhibiting TRPM2 activ-
ity in COPD would have no anti-inflammatory effect.
Methods
Animals
Male and female TRPM2-deficient mice [7] and their wild
type counterparts were backcrossed onto BALB/C using
the speed congenics service, MAX-BAX
® (Charles River).
The genotype was confirmed using DNA isolated from
blood samples. Animals were kept at an ambient tempera-
ture of 22 ± 2°C under a 12 hours normal phase light-dark
cycle. Food and drinking water was freely available and
animals were acclimatized for a period of at least 7 days
upon arrival in the animal house prior to initiation of any
experimental work. The ozone exposure experiments were
carried out at Novartis Basel (Switzerland) with the
approval of the Veterinary Authority of the City of Basel
(Kantonales Veterinaeramt, Basel-Stadt). All other experi-
ments were carried out at Novartis Horsham (UK) under
a Project License issued by the United Kingdom Home
Office under the Animal (Scientific Procedures) Act 1986
and approved by local ethical review processes.
Ozone exposure
The protocol was modified from Williams et al. [8].
Unrestrained mice were placed in plastic exposure cham-
ber of the following dimensions: 23 cm wide, 48 cm deep
and 17 cm height (0.1 m2) (maximum of 5 mice per
chamber) and exposed to 3 parts per million (ppm) ozone
or room air for 4 hours. Ozone was generated, at a flow of
480 l/h, and monitored using a computer-controlled
ozone simulator system (SIM6050-T; Anseros GmbH,
Germany). Animals were killed 3 and 24 hours post
exposure.
LPS challenge
Mice were challenged intranasally, as previously described
[9], with 0.3 mg/kg of lipopolysaccharide (E. coli serotype
0111:B4) or its vehicle (isotonic saline, 25 μl). Animals
were killed at 3 and 24 hours post challenge.
Tobacco smoke exposure and exacerbation models
The protocol was modified from our previous studies per-
formed in rats [10]. Unrestrained mice were placed in
plastic wholebody exposure chambers (maximum of
10 mice per chamber) and exposed to mainstream tobacco
smoke for 30 minutes, twice a day on three consecutive
days with at least a 5 hours gap between each exposure.
Tobacco smoke was generated, at a flow rate of 0.6 l/min,
using 1R3F Kentucky Research cigarettes and monitored
using an EMMS (Bordon UK) total particulate matter
transducer (mean wet total particulate matter of 406 ±
7 μg/l). Sham animals were exposed to room air only. For
the exacerbation model, on the morning of day 3 animals
were administered LPS (E. coli serotype 0111:B4;0 . 3m g /
ml or saline, intranasally). Five hours after the LPS chal-
lenge, animals were exposed to tobacco smoke for 30 min-
utes. In both models, animals were killed 18 hours after
the last tobacco smoke exposure.
Assessment of airway inflammation
At the indicated time point, terminal anesthesia was
induced with pentobarbitone sodium (60 mg/kg, intra-
peritoneally). The trachea was cannulated and bronchoal-
veolar lavage (BAL) was performed by instilling g 3 times
0.4 ml of phosphate buffered saline into the lung via the
trachea. Total cell counts were measured and cytospins
prepared. Cells were stained with Diff-Quik and a
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morphological criteria. Immediately after BAL was per-
formed, the top right lung lobe was removed and snap
frozen in liquid nitrogen for subsequent analysis. This
lung lobe was homogenized in phosphate buffered saline
containing a protease inhibitor cocktail (Roche, UK). For
the ozone experiment, CXCL1, CXCL2, IL-6 (R&D Sys-
tems, Abingdon, UK and plasma albumin (Bethyl labora-
tories, Montgomery, TX, USA) were determined using
ELISAs according to the manufacturer’s instructions. For
the tobacco smoke experiments cytokine analysis was
performed using 7-plex pro-inflammatory cytokine
mesoscale discovery (MSD) assay following manufac-
turer’s instructions. Lactate dehydrogenase activity was
assessed using a Cytotoxicity detection kit following
manufacturer’s instructions (Roche, UK).
In vitro functional assays
Peripheral blood was collected from the abdominal vena
cava of mouse. Pooled blood from 4 mice was used to
assess neutrophil shape change. Agonists (10 μl) were
added to 80 μl of blood for 5 minutes at 37°C followed by
fixation with 2.5% paraformaldehyde (Cell Fix™,B D ) .R e d
blood cells were lysed using ice cold lysis buffer (1.5 mM
NH4Cl and 0.1 mM KHC03). Forward scatter/side scatter
(FSC/SSC) plots were used to gate granulocytes (FACSCa-
libur, Becton Dickinson). The gated neutrophils were
distinguished in FSC/FL2 plots and the mean FSC value
was used as a measure of shape change.
Mouse bone marrow neutrophils were isolated from
femurs and tibias from 4 mice. Bone marrow cells were
pelleted by centrifugation and suspended in 5 ml of PBS.
Thirteen ml of 65% Percoll (GE Healthcare) was layered
on to 13 ml of a 75% Percoll solution. The cell suspension
was layered on top of the gradient. After centrifugation at
1600 × g for 30 min, the neutrophil fraction between the
75 and 65% layer was collected. HTS-transwell-96 well
plates with 3 μm pore size membranes (Costar) were used
to determine chemotaxis of calcein-AM (0.5uM) labelled
neutrophils. The medium containing chemoattractant was
added to the lower chamber. Neutrophils (5 × 10
5 cells)
were allowed to migrate from the upper to lower chamber
for 1 hour and the number of migrating cells was quanti-
tated by reading the lower plate on a fluorescence plate
reader (BioTek Synergy) at 485 nm excitation and 520 nm
emission.
Mouse bone marrow monocytes were isolated from
femurs and tibias from 4 mice. Bone marrow cells were
pelleted by centrifugation. The collected bone marrow
cells were counted and the monocytes were isolated by
CD11b positivity using a magnetic activated cell sorting
system (Miltenyi Biotech). CD11b
+ cells were seeded into
96 well plates at 1.10
5 per well in RPMI 1640 medium
(supplemented with 10% fetal bovine serum, 5 mM L-
Figure 1 TRPM2 deficiency has no effect on the ozone-induced BAL inflammation. TRPM2-deficient mice (grey bars) or their wild type
counterpart (white bars) were exposed to ozone (3 ppm for 4 hours, hatched bars) or air (plain bars) as described in methods section. Animals
were killed for bronchoalveolar lavage differential cell counts and soluble mediator measurement at 3 and 24 hours after the end of exposure.
Data are shown as mean ± SEM of 2 different experiments, each including 10-11 animals per group. Significance (P < 0.05), indicated by *, is
against the air-exposed mice for each strain. No statistical significance was observed between deficient and wild type animals on all the
parameters measured.
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mycin). Cells were stimulated with LPS (E. Coli, 055:B5)
for a period of 6 or 24 hours. Cell free supernatants were
collected and assayed for CXCL2 (R&D Systems Duo set
ELISA kit) and IL-10, IL-6 and TNF-a (Mesoscale
Discovery).
Data analysis
Data are expressed as mean ± standard error of the mean
(SEM). Statistical significance (P < 0.05) was determined
by analysis of variance with Kruskal-Wallis and Dunns
multiple comparison test (GraphPad Software, San Diego,
CA, USA).
Results and discussion
In vivo models
TRPM2 is expressed in various inflammatory cells (i.e.
neutrophil, macrophage and monocyte) and has been
implicated in oxidative stress-induced inflammatory
response in these cell types [11]. Therefore, we compared
the response of wild type and TRPM2-deficient mice in a
model of ozone-induced airway inflammation. At 3 hours
post ozone exposure, when compared to air-exposed ani-
mals, wild type mice had an increased number of BAL
neutrophils together with elevated levels of BAL CXCL1,
CXCL2, IL-6 and serum albumin (a marker of plasma
leakage). At 24 hours post ozone exposure, neutrophil
numbers and serum albumin levels were still elevated,
whereas CXCL1, CXCL2 and IL-6 levels had returned to
baseline. BAL macrophage numbers were only elevated at
the 24 hours time point. At both time points and for all
the parameters measured no difference could be observed
when comparing the wild type mice with TRPM2-deficient
mice (Figure 1).
Since no differences were observed between wild type
and TRPM2-deficient mice in an exogenous model of oxi-
dative stress-induced airway inflammation, we went on to
study the possible role of TRPM2 in a mechanistic model
of endogenously mediated oxidative stress (i.e. infiltrating
inflammatory cells following LPS challenge). At 3 hours
post LPS challenge, when compared to saline-challenged
animals, wild type mice had an increased number of BAL
total cells and neutrophil numbers together with increased
levels of lung IL-1b, IL-6 and CXCL1. At 24 hours post
Figure 2 TRPM2 deficiency has no effect on the LPS-induced BAL inflammation and lung cytokine production. TRPM2-deficient mice
(gray bars) or their wild type counterpart (white bars) were challenged with LPS (hatched bars) or saline (plain bars) as described in methods.
Animals were killed for bronchoalveolar lavage differential cell counts and lung soluble mediator measurement at 3 and 24 hours post challenge.
Data are shown as mean ± SEM of 7-8 animals per group. Significance (P < 0.05), indicated by *, is against the air-exposed mice for each strain.
No statistical significance was observed between deficient and wild type animals on all the parameters measured.
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lung IL-1b and IL-6 levels were still elevated. BAL lactate
dehydrogenase (LDH) activity (a marker of tissue damage)
and protein levels (a marker of lung edema) were only
elevated at the 24 hours time point. BAL macrophage
numbers were not affected by the LPS challenge (Figure 2).
At 3 hours post LPS challenge the following cytokine/che-
mokines were also increased in the BAL: IFN-g,I L - 1 0 ,
IL-12p70, IL-1b,C X C L 1 ,I L - 6 ,T N F - a and CXCL2. The
levels of BAL IL-10, CXCL1, IL-6 and TNF-a decreased
towards baseline but were still significantly increased,
whereas the levels of CXCL2 had returned to baseline.
Levels of IFN-g, IL-12p70 and IL-1b were either increased
or sustained at the 24 hours time point (Figure 3). At both
time points and for all the parameters measured no differ-
ence could be observed when comparing the wild type
mice with TRPM2-deficient mice (Figures 2 & 3). During
the preparation of this manuscript, a report studying the
lung inflammatory response in TRPM2-deficient mice
following endotoxin challenge was published. In contrast
to our data, the authors reported an increased production
of lung chemokines/cytokines in the lung of the TRPM2-
deficient mice when compared to their wild type counter-
part as well as an increased sequestration of neutrophils
into the lung [12]. A major difference between this recent
study [12] and our work is the route of administration for
LPS. We have used intranasal dosing whereas Di and col-
leagues [12] used intraperitoneal dosing. This could explain
the differences observed between the two studies as the
LPS-induced lung inflammation is highly dependent on the
route of dosing. As such, only following local lung applica-
tion of LPS can neutrophils be detected in the airway space
[13]. Another difference between the two studies is that we
have monitored the cellular inflammation in the BAL,
whereas Di and colleagues used lung myeloperoxidase as a
surrogate for neutrophil influx. In addition, Di and collea-
gues have used C57BL/6 mice, a strain we have shown to
be a lower responder to LPS when compared to BALB/c
Figure 3 TRPM2 deficiency has no effect on the LPS-induced BAL cytokine production. TRPM2-deficient mice (gray bars) or their wild type
counterpart (white bars) were challenged with LPS (hatched bars) or saline (plain bars) as described in methods. Animals were killed for
bronchoalveolar lavage soluble mediator measurement at 3 and 24 hours post challenge. Data are shown as mean ± SEM of 7-8 animals per
group. Significance (P < 0.05), indicated by *, is against the air-exposed mice for each strain. No statistical significance was observed between
deficient and wild type animals on all the parameters measured.
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apparent discrepancy between the two studies.
In view of the lack of effect of TRPM2 deficiency in
the above mechanistic models of oxidative stress-
induced airway inflammation, we went on to compare
the response of wild type and TRPM2-deficient mice in
a more disease relevant model and used tobacco smoke
to induce lung inflammation. When compared to air-
exposed wild type mice, animals exposed to tobacco
smoke had elevated BAL total cell and neutrophil num-
bers and a decreased number of BAL macrophages. BAL
LDH activity and protein levels as well as lung levels of
IL-1b and CXCL1 were elevated (Figure 4). Tobacco
smoke exposure also increased the levels of BAL IL-10,
IL-12p70, IL-1b,C X C L 1 ,I L - 6a n dT N F - a (Figure 5).
For all the parameters measured no differences were
found when comparing the wild type mice with
TRPM2-deficient mice (Figure 4 & 5). Finally, an
exacerbation model combining tobacco smoke exposure
and LPS challenge was investigated. In agreement with
the experiments reported above (Figures 2, 3, 4, 5),
exposure to LPS or tobacco smoke alone induced a BAL
inflammation that was not significantly different
b e t w e e nw i l dt y p em i c ea n dT R P M 2 - d e f i c i e n tm i c e
(Figure 6). When both stimuli were combined, the
increase in BAL cellular inflammation as well as LDH
activity, protein and CXCL1 levels were mainly driven
by the LPS challenge. An additive effect was seen for
the levels of BAL IL-1b,I L - 6a n dT N F - a.F o ra l lt h e
parameters measured, in the mice exposed to tobacco
Figure 4 TRPM2 deficiency has no effect on the tobacco smoke-induced BAL inflammation and lung cytokine production.T R P M 2 -
deficient mice (gray bars) or their wild type counterpart (white bars) were exposed to tobacco smoke (hatched bars) or air (plain bars) as
described in methods. Animals were killed for bronchoalveolar lavage differential cell counts and bronchoalveolar lavage and lung soluble
mediator measurement 18 hours after the end of last exposure. Data are shown as mean ± SEM of 10-11 animals per group. Significance (P <
0.05), indicated by *, is against the air-exposed mice for each strain. No statistical significance was observed between deficient and wild type
animals on all the parameters measured.
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paring the wild type mice with TRPM2-deficient mice
(Figure 6).
Utilizing different models of either exogenous or
endogenous oxidative stress-induced airway inflamma-
tion, we could not demonstrate a role for TRPM2 in the
inflammatory response. This is somewhat in contrast to
a recent publication showing that TRPM2-deficient
mice had an attenuated neutrophil infiltration and
CXCL2 production in a dextran sulfate sodium-induced
ulcerative colitis model [7]. However, it is interesting to
note that the beneficial effect observed with the
TRPM2-deficient mice was almost exclusively driven by
an inhibition of CXCL2 production and other pro-
inflammatory cytokines such as IL-6 or several CCL
chemokines were not affected [7]. This would suggest
that TRPM2 inhibition would not have a general anti-
inflammatory effect but rather selectively inhibits some
of the pro-inflammatory mediators. The results obtained
in the dextran sulfate sodium model are not surprising
and in line with the published literature. Indeed, the
production and release of reactive oxygen species by
immune cells play a crucial role in the development of
colitis [14] and CXCL2 has a detrimental role in this
model [15] whereas other neutrophil chemoattractants
such as CXCL1 have a protective role [16]. This is in
contrast to several mouse airways inflammatory models
where both CXCL1 and CXCL2 have been shown to
have a crucial role in the development of the neutrophi-
lic inflammation [17]. Based on these observations, one
would expect a selective inhibition of CXCL2 in models
of airway inflammatory diseases not to translate into a
meaningful effect on the overall inflammation. Never-
theless, in our in vivo models, no difference in CXCL2
production or release of other pro-inflammatory media-
tors was observed between wild type mice and TRPM2-
deficient mice. In order to further investigate these dis-
c r e p a n c i e s ,w es t u d i e dt h er o l eo fT R P M 2i ni nv i t r o
assays of neutrophil chemotaxis and CD11 + cells
activation.
In vitro neutrophil chemotaxis and CD11
+ cells activation
We first investigated whether TRPM2 plays a role in
neutrophil chemotaxis induced by various stimuli. Using
whole blood from wild type mice, a concentration-
dependent neutrophil shape change was observed when
the cells were stimulated with CXCL1, CXCL2 and C5a.
For all the stimuli used, no difference could be detected
when comparing neutrophils from wild type and
TRPM2-deficient mice. The same stimuli also induced
chemotaxis of neutrophils, isolated from the bone mar-
row, and again no difference could be observed when
comparing neutrophils from wild type or TRPM2-defi-
cient mice (Figure 7). These results are in agreement
Figure 5 TRPM2 deficiency has no effect on the tobacco smoke-induced BAL cytokine production. TRPM2-deficient mice (gray bars) or
their wild type counterpart (white bars) were exposed to tobacco smoke (hatched bars) or air (plain bars) as described in methods. Animals
were killed for bronchoalveolar lavage soluble mediator measurement 18 hours after the end of last exposure. Data are shown as mean ± SEM
of 10-11 animals per group. Significance (P < 0.05), indicated by *, is against the air-exposed mice for each strain. No statistical significance was
observed between deficient and wild type animals on all the parameters measured.
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Page 7 of 10Figure 6 TRPM2 deficiency has no effect on the tobacco smoke/LPS-induced BAL inflammation. TRPM2-deficient mice (gray bars) or their
wild type counterpart (white bars) were sham-exposed (plain bars) or exposed to LPS (horizontal hatched bars), tobacco smoke (left hatched
bars, TS) or their combination (right hatched bars, TS/LPS) as described in methods. Animals were killed for bronchoalveolar lavage differential
cell counts and soluble mediator measurement 18 hours after the end of last exposure. Data are shown as mean ± SEM of 9-11 animals per
group. Significance (P < 0.05), indicated by *, is against the air-exposed mice for each strain. No statistical significance was observed between
deficient and wild type animals on all the parameters measured.
Figure 7 TRPM2 deficiency has no effect on blood neutrophil shape change and chemotaxis to various stimuli. Neutrophils were isolated
from either TRPM2-deficient mice (plain circle) or their wild type counterpart (open circle) and shape change, using whole blood, or chemotaxis, using
purified neutrophil from bone marrow, to various stimuli was measured. Data are shown as mean ± SEM of 3 different experiments.
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induced neutrophil chemotaxis is not dependent on
TRPM2 activation [17]. They also extend these results,
in that CXCL1, another important airway neutrophil
chemoattractant [17], does not require TRPM2 to
induce neutrophil chemotaxis [7].
Since monocytes/macrophages are also key cells in the
development of the airway inflammation in the in vivo
models used above, we studied whether TRPM2 would
have any involvement in their activation driven by oxida-
tive stress. H2O2-induced a concentration-dependent (3-
300 μM) Ca
2+ influx in CD11
+ cells purified from both
wild type and TRPM2-deficient mice. A 31% decrease in
the Ca
2+ signal was observed in the TRPM2-deficient
monocyte, but only when stimulated with 10 μMH 2O2
(data not shown). H2O2 stimulation (100 μM) also induced
the release of CXCL2 that was reduced by about 40% in
the deficient mice when compared to wild type animals
(in pg/ml: wild type, 61.2 ± 20.4; deficient, 37.8 ± 5.2, not
significant). Similarly, when using another oxidative sti-
muli, 10% cigarette smoke condensate, a numerical
decrease in the levels of CXCL2 released from the CD11
+
cells isolated from deficient mice was observed (in ng/ml:
wild type, 1.01 ± 0.25; deficient, 0.75 ± 0.07, not signifi-
cant). These data are in agreement with previously pub-
lished results describing a partial inhibition of H2O2-
induced CXCL2 production from CD11
+ cells isolated
from TRPM2-deficient mice [7]. However, using LPS as a
stimulus we could not confirm a role for TRPM2 in CD11
+ cells activation [7]. In our hands, LPS induced a concen-
tration- and time-dependent release of IL-10, IL-6, TNF-a
and CXCL2 from mouse CD11
+ cells. The same stimuli
also induced activation of CD11
+ cells isolated from
TRPM2-deficient mice and no difference could be evi-
denced when comparing cells isolated from wild type mice
with TRPM2-deficient mice (Figure 8).
Although, the in vitro experiments described above sug-
gest some difference in the activation of CD11
+ cells when
comparing wild type mice with TRPM2-deficient mice,
these differences were minute and stimuli-dependent. It is
therefore unsurprising that they do not translate into a
relevant physiological effect. Hence, our in vitro data is
supportive of the lack of effect of TRPM2 deficiency
observed in all the in vivo models of oxidative stress-
induced lung inflammation used in the present study.
Since several studies have linked TRPM2 activation and
oxidative stress [11], the lack of effect of TRPM2 defi-
ciency in our in vivo and in vitro models could seems
somewhat surprising. However, a closer look at the litera-
ture might well support our data. In addition to the
CXCL2-selective effect described above [7], in the human
monocytic cell line THP-1, only a partial inhibition of
LPS-induced pro-inflammatory cytokine release was
observed following downregulation of TRPM2 using
shRNA despite a full inhibition of the LPS-induced intra-
cellular calcium increase [18]. In human neutrophils, it
was shown that fMLP-induced calcium influx and chemo-
taxis was TRPM2 dependent [19,20]. In contrast stimula-
tion of human neutrophil with PAF was independent of
TRPM2 [20]. Consistent with the human situation, fMLP-
but not CXCL2-induced calcium and migration responses
were reduced in neutrophils from TRPM2-deficient mice
[7]. All these data, including ours, suggest that the contri-
bution of TRPM2 to neutrophil and/or monocyte
responses is highly dependent on the stimuli but also on
the read out studied. In addition, more recent data suggest
Figure 8 TRPM2 deficiency has no effect on LPS-induced CD11+ cells activation. Bone marrow CD11+ cells were isolated from either
TRPM2-deficient mice (plain circle) or their wild type counterpart (open circle) and stimulated with various stimuli for 6 or 24 hours for
measurement of pro-inflammatory mediators. Data are shown as mean ± SEM of 3 different experiments.
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trophils [21], is more important than TRPM2 in mediating
intracellular calcium increase in responses to H2O2 [22].
Conclusion
We have shown that in a mechanistic model of oxidative
stress-induced lung injury (ozone exposure) and in sev-
eral models thought to reproduce aspects of the inflam-
mation observed in COPD, TRPM2-deficiency did not
affect the development of airway inflammation. These
data suggest that TRPM2 blockers may not have benefi-
cial effects in patients with COPD.
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